The Netherlands: VectorY makes key appointments following close of seed funding

Amsterdam-based biotech company, VectorY, has appointed Alexander Vos as CEO, and Dr Sander van Deventer as CTO. The appointments come in the wake of the company closing a €31m (US$37.6m) seed financing round. Vos brings over 25 years of leadership experience in the biotech industry, having held senior positions at multiple private and public biopharma…

You must be a HMI Subscriber to view this content.

Subscribe Now »